Please try another search
NanoEntek, Inc. engages in the research and development, production, and sale of life-science lab equipment, in vitro diagnostic medical devices, point of care diagnostic devices, and related consumables and solutions in Korea and internationally. It provides FREND system, a fluorescence immunoassay analyzer; BUDDI, a rapid diagnostic test analyzer; rapid diagnostic test items; ADAM-rWBC, a residual white blood cell counters; ADAMII/fluorescence stem cell counter; fluorescence cell counters and cell analyzers; brightfield cell counters; somatic cell counters; live-cell imaging system; and disposable hemocytometers. The company was founded in 1987 and is headquartered in Seoul, South Korea.
Name | Age | Since | Title |
---|---|---|---|
Jin-Hyung Park | 54 | - | Chief Executive Officer and Director |
Tae-Sun Yook | 56 | - | Non-Standing Director |
Yong-Jin Kim | 52 | - | Auditor |
Kyung-Il Park | 52 | - | Director |
Myung-Rib Kim | 54 | - | Director |
Jung-Goo Seo | 61 | 2015 | Vice-President and Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review